Recent studies have found that high levels of NEIL3 and circNEIL3 could promote carcinogenesis, metastasis and drug resistance in several ways, including HCC, NSCLC, GBM, cervical cancer and PDAC, and were strongly associated with poor prognosis of these cancers. Here, NEIL3 is linked to glioblastoma.